Hospital News and Research

RSS

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

Researchers at Institut Hospital del Mar d'Investigacions M-diques (IMIM) in Barcelona, in collaboration with the Icahn School of Medicine at Mount Sinai in New York and other U.S. Institutions, have found that intestinal mucus not only acts as a physical barrier against commensal bacteria and dietary antigens, but also prevents the onset of inflammatory reactions against these agents.

27 Sep 2013

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine.

27 Sep 2013

Drug misuse predicts protracted hospital stay for schizophrenia patients

Patients hospitalized with schizophrenia have more severe symptoms and spend longer in hospital if they have a concurrent substance use disorder, report researchers.

26 Sep 2013

T. gondii antibodies implicated in mania

Infection with Toxoplasma gondii may confer an increased risk for mania, say researchers.

26 Sep 2013

Alder Hey Children’s Hospital, FACT seek volunteers to take part in Headspace project

Alder Hey Children’s Hospital and FACT are looking for volunteers to take part in a groundbreaking project which will impact on the future development of craniofacial surgery. The Headspace project, created by Alder Hey in conjunction with FACT and associated artists will develop a comprehensive database of human head shapes using state of the art 3D photography.

26 Sep 2013

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil System for patients with severe emphysema.

26 Sep 2013

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the initiation of a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome. The first patient has been dosed in the IMAGO Phase II study being conducted in the U.K., and enrollment of pediatric patients is expected to begin later this year in the ITCH Phase II study in the U.S.

26 Sep 2013

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

From today, patients with a very aggressive form of breast cancer known as HER2-positive, could benefit from a new faster, more efficient delivery method of Herceptin. The subcutaneous injection, given just beneath the skin, can be completed in 2-5 minutes, compared to the traditional, relatively time-consuming 30-90 minute intravenous infusion.

26 Sep 2013

First Edition: September 26, 2013

Today's headlines include details regarding the ongoing congressional battle over the future of the health law in the context of avoiding a government shutdown, as well as the developments on the ground as the Oct. 1 launch of the health law's insurance marketplace nears.

26 Sep 2013

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

President Obama, President Clinton, and Senator Ted Cruz all spent a lot of time talking about Obamacare on Tuesday. But the real news came just as the day was ending, right at midnight, when the Department of Health and Human Services released data on insurance premiums available through the new Obamacare marketplaces. Several states had already released their data. With this report, HHS provided premium information for most of the rest. Overall, the numbers are pretty consistent with previous reports, albeit with some new and interesting wrinkles. It seems like mostly good news, though the law's critics would argue it vindicates some of their arguments, as well (Jonathan Cohn, 9/25).

26 Sep 2013

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.

26 Sep 2013

Finding innovative ways to manage total cost of care

The American Medical Group Association is convening more than 450 participants, representing the leaders of the nation's preeminent healthcare provider organizations, at the IQL 2013 Annual Conference, September 25 - 27 at The Phoenician in Scottsdale, Arizona.

26 Sep 2013

Three research groups awarded NIH grants to develop framework for evaluating genetic variants

Three grants totaling more than $25 million over four years will help three research groups to develop authoritative information on the millions of genomic variants relevant to human disease and the hundreds that are expected to be useful for clinical practice. The awards are from the National Institutes of Health.

26 Sep 2013

Banning the use of harmful flame retardants lowers exposures in pregnant women

Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.

26 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Inhibiting use of antibiotics may be more effective in reducing C.diff infection

New ways are needed to fight the infection Clostridium difficile and better use of antibiotics could be key, according to the authors of ground-breaking research.

26 Sep 2013

Targeting cell-division cycle may lead to improved outcomes for patients with medulloblastoma

A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham).

26 Sep 2013

Spanish scientists discover melatonin consumption helps control weight gain

Melatonin is a natural hormone segregated by the body and melatonin levels generally increase in the dark at night. It is also found in fruit and vegetables like mustard, Goji berries, almonds, sunflower seeds, cardamom, fennel, coriander and cherries.

26 Sep 2013

Stroke warning for bipolar patients

Patients with bipolar disorder are at an increased risk for having a stroke and for dying soon after their stroke, a study shows.

25 Sep 2013

Research finds no increased risks of mortality for early-stage breast cancer patients receiving XRT

Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting.

25 Sep 2013

Hospital News and Research

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

Drug misuse predicts protracted hospital stay for schizophrenia patients

T. gondii antibodies implicated in mania

Alder Hey Children’s Hospital, FACT seek volunteers to take part in Headspace project

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

First Edition: September 26, 2013

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

Finding innovative ways to manage total cost of care

Three research groups awarded NIH grants to develop framework for evaluating genetic variants

Banning the use of harmful flame retardants lowers exposures in pregnant women

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Inhibiting use of antibiotics may be more effective in reducing C.diff infection

Targeting cell-division cycle may lead to improved outcomes for patients with medulloblastoma

Spanish scientists discover melatonin consumption helps control weight gain

Stroke warning for bipolar patients

Research finds no increased risks of mortality for early-stage breast cancer patients receiving XRT

Industry Focus eBook - Cell biology (5th edition) eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News